EP Wealth Advisors LLC Sells 366 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

EP Wealth Advisors LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 24.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,133 shares of the biotechnology company’s stock after selling 366 shares during the quarter. EP Wealth Advisors LLC’s holdings in Axon Enterprise were worth $673,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Asset Dedication LLC raised its holdings in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC raised its stake in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the period. Beacon Pointe Advisors LLC boosted its position in Axon Enterprise by 2.6% during the 4th quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company’s stock valued at $513,000 after acquiring an additional 22 shares in the last quarter. Finally, Burns Matteson Capital Management LLC grew its holdings in shares of Axon Enterprise by 3.4% during the 4th quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock worth $450,000 after acquiring an additional 25 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.3 %

Axon Enterprise stock opened at $684.59 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a fifty day simple moving average of $564.50 and a two-hundred day simple moving average of $584.84. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $53.29 billion, a price-to-earnings ratio of 176.90, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. Axon Enterprise’s revenue for the quarter was up 31.3% on a year-over-year basis. During the same period last year, the company earned $1.15 EPS. Equities analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research note on Thursday. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $640.91.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.